Ready for an inspection
you didn't get advance notice of.
CDSCO's 2025-2026 enforcement posture is active, not theoretical — monthly compliance reporting from state and UT drug controllers, immediate inspection for manufacturers who missed the extension window, and a rising NSQ classification rate. ValiCore keeps the exact records CDSCO checks always current, not reconstructed under deadline pressure.
What does CDSCO inspect during a compliance audit?
CDSCO — the Central Drugs Standard Control Organisation, India's National Regulatory Authority under the Ministry of Health & Family Welfare — conducts compliance inspections under revised Schedule M that specifically check: Pharmaceutical Quality System (PQS) implementation in actual daily operation, Quality Risk Management (QRM) application to real decisions (not just documentation), Product Quality Review (PQR) completion, equipment qualification and validation status, computerised (electronic) record-keeping for drug product records, and ALCOA+-aligned data-integrity discipline throughout. State and UT drug controllers now report inspection findings to CDSCO on a monthly cadence — a sustained enforcement posture through 2026, not a one-time compliance sweep.
Built for
What goes wrong without it
Immediate inspection exposure
As of January 1, 2026, manufacturers who didn't apply for a compliance extension are subject to immediate CDSCO inspection under revised Schedule M — with reports indicating the large majority of eligible firms never filed for extension.
NSQ classification is rising, not falling
1,879 batches classified Not-of-Standard-Quality in 2025, versus 877 in 2024 — enforcement intensity is increasing, and a single NSQ classification can trigger recall obligations and reputational damage beyond the immediate finding.
Recall and Rapid Alert System obligations
CDSCO's Recall & Rapid Alert System guidelines mean a quality signal — whether manufacturer-initiated or CDSCO-mandated — needs to move through the SUGAM portal with documented evidence, fast. A slow, manual recall process compounds the original problem.
What ValiCore actually does here
PQS demonstrated in daily operation
CAPA, change control, and deviation handling run through one system — so a CDSCO inspector sees the PQS operating, not described.
Revised Schedule MStructured QRM applied to real decisions
Risk assessments tracked as first-class records across change control and supplier qualification, not confined to a validation exercise.
PQR data aggregation
APQR module pulls batch trends, complaints, and deviations into the periodic review CDSCO checks for completion of.
Equipment validation with full evidence chain
IQ/OQ/PQ tied to risk assessment and change control — the qualification status CDSCO verifies during inspection.
Computerised record-keeping, tamper-evident
Every GMP record in one hash-chained system — satisfying the computerised-storage requirement directly, with a verifiable integrity check.
Recall workflow tied to the Rapid Alert System
Recall records structured for fast, documented escalation — batch numbers, distribution scope, and root cause in one traceable record.
Regulations this addresses
Related modules
Frequently asked questions
A Not-of-Standard-Quality (NSQ) classification typically triggers a formal investigation into root cause, may require notification through CDSCO's Rapid Alert System, and can lead to recall obligations for the affected batch and potentially related batches from the same process. Manufacturers should expect increased regulatory scrutiny following an NSQ classification, making a fast, well-documented investigation critical to limiting the scope of consequences.
Inspection frequency varies by risk profile, past compliance history, and current enforcement priorities — but the 2025-2026 posture is notably active: state and UT drug controllers report findings to CDSCO monthly, and manufacturers who missed the Schedule M extension-filing deadline are now subject to immediate inspection rather than a scheduled, advance-notice visit.
SUGAM is CDSCO's online regulatory portal used for a range of drug regulatory processes in India, including routing alerts and communications tied to the Rapid Alert System for recalls and quality signals. Manufacturers responding to a recall or quality alert typically interact with CDSCO's process through this system.
See ValiCore
live in your lab.
Book a free 30-minute demo. We’ll walk through the modules your team will use, answer your compliance questions, and give you a clear picture of what implementation looks like for your lab.
Book your free demo
30 minutes. No credit card. We’ll respond within 4 business hours with a calendar invite tailored to your time zone.
Book my free demo35 working modules · Founder-led onboarding · 14-day go-live guarantee